Page 10 – Children's Tumor Foundation

Six people stand on an outdoor balcony, posing for a group photo. They are dressed in formal and semi-formal attire. A brick building and blue sky are visible in the background.

Press Release Special Events Ways to Give

‘Dancing with Our Stars’ Gala Returns to the Wally Allen Ballroom to Raise Money for Rare Genetic Disorder

NF1 Story of NF

Stories of NF: Andrea M

Dr Vincent Riccardi

Featured Featured EU Science & Research

Honoring the Legacy of Vic Riccardi: A Pioneer in NF Research

Two people seated on stage in discussion during the "Fireside Chat with Innovative Health Initiative" at a Children's Tumor Foundation Europe event. A screen behind them displays the event title.

Featured Global NF Conference Press Release Science & Research Top Story EU

Children’s Tumor Foundation Europe Leads Collective Effort in Accelerating Therapeutics and Innovation for Rare Diseases

Text on a plain background reads: "MAKE NF RESEARCH VISIBLE" and "WHY JOIN THE NF FIELD?" in blue and green letters.

Science & Research Video

Young Researchers and Clinicians: Join the NF Field

A woman stands by a wooden railing overlooking a coastal landscape with mountains and a sandy beach in the background. She is wearing a light coat and carrying a small bag.

NF2-SWN Story of NF

Stories of NF: Rozalinda H

Collaborations & Partnerships NF1 Outside Opportunities

Funding Opportunity: 2025 Francis S. Collins Scholars

Opening Address slide featuring Nathalie Moll, Director General, EFPIA - European Federation of Pharmaceutical Industries and Associations, with a globe and abstract light design background.

Featured EU Global Pharma

Nathalie Moll, Director General of EFPIA, Delivered the Opening Address at the Global NF Conference

Two individuals on stage smile while holding an award. They stand beside a podium with the text "Global NF Conference." One person holds a plaque with the words "2014 Friedrich von Recklinghausen Award.

Awards & Grants Science & Research

Children’s Tumor Foundation Names Rosalie Ferner, MD, 2024 Friedrich von Recklinghausen Award Winner

Graphical abstract from The New England Journal of Medicine showing the effects of Brigatinib in NF2-related Schwannomatosis, indicating a decrease in tumor volume for various target tumors.

Collaborations & Partnerships NF2-SWN Press Release Publications Science & Research Top Story Top Story EU

Brigatinib Shows Promise for NF2-SWN: A Direct Result of CTF’s Synodos Initiative

Previous 1 … 8 9 10 11 12 … 156 Next